Skip to main content

Table 3 Frequencies of various adjunct treatments for severe sepsis during the first 7 days after the ICU admission

From: Characteristics, treatments, and outcomes of severe sepsis of 3195 ICU-treated adult patients throughout Japan during 2011–2013

Adjunct treatments  
 DIC treatments 1498 (47%)
  Antithrombin 990 (31%)
  Thrombomodulin 856 (27%)
   Co-administration of antithrombin and thrombomodulin 496 (16%)
  Protease inhibitors 392 (12%)
  Heparinoids 167 (5%)
 Immunoglobulin 976 (31%)
 Low-dose steroids 777 (24%)
 Renal replacement therapy 890 (28%)
 Non-renal indication renal replacement therapy 266 (8%)
 Polymyxin B-direct hemoperfusion 692 (22%)
  1. Data are presented as number (percentage)
  2. DIC disseminated intravascular coagulation, ICU intensive care unit